BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 9519960)

  • 1. Redefining vitamin D insufficiency.
    Malabanan A; Veronikis IE; Holick MF
    Lancet; 1998 Mar; 351(9105):805-6. PubMed ID: 9519960
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary Hyperparathyroidism in a Patient with CKD.
    Hyder R; Sprague SM
    Clin J Am Soc Nephrol; 2020 Jul; 15(7):1041-1043. PubMed ID: 32461217
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperparathyroidism in deficiency rickets. Changes after vitamin therapy].
    Mallet E; Bousnina S; Tron P; Basuyau JP; Brunelle P; de Menibus CH
    Arch Fr Pediatr; 1977; 34(7):632-8. PubMed ID: 201225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary hyperparathyroidism in elderly people: combined effect of renal insufficiency and vitamin D deficiency.
    Freaney R; McBrinn Y; McKenna MJ
    Am J Clin Nutr; 1993 Aug; 58(2):187-91. PubMed ID: 8338046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
    Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
    J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When is Vitamin D contraindicated in dialysis patients?
    Martin KJ
    Semin Dial; 2009; 22(3):247-9. PubMed ID: 19573001
    [No Abstract]   [Full Text] [Related]  

  • 7. Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial.
    Shroff R; Wan M; Gullett A; Ledermann S; Shute R; Knott C; Wells D; Aitkenhead H; Manickavasagar B; van't Hoff W; Rees L
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):216-23. PubMed ID: 22266572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vitamin D deficiency, still a frequent problem in geriatrics].
    Trivalle C; Giot JL; Lefebvre-Chapiro S; Feteanu D; Guillemant S; Sebag-Lanoë R
    Presse Med; 2004 Mar; 33(6):392. PubMed ID: 15105783
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of vitamin D deficiency in man.
    Preece MA; TomlinsonS ; Ribot CA; Pietrek J; Korn HT; Davies DM; Ford JA; Dunnigan MG; O'Riordan JL
    Q J Med; 1975 Oct; 44(176):575-89. PubMed ID: 172936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When is Vitamin D contraindicated in dialysis patients?
    Khosla N; Sprague SM
    Semin Dial; 2009; 22(3):249-51. PubMed ID: 19573002
    [No Abstract]   [Full Text] [Related]  

  • 11. When is Vitamin D Contraindicated in Dialysis Patients?
    Goodman WG
    Semin Dial; 2009; 22(3):245-7. PubMed ID: 19573000
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of vitamin d receptor activators in cardio-renal syndromes.
    Cozzolino M; Bruschetta E; Stucchi A; Ronco C; Cusi D
    Semin Nephrol; 2012 Jan; 32(1):63-9. PubMed ID: 22365164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vitamin D therapy in predialysis renal failure].
    Ando R
    Clin Calcium; 2004 Sep; 14(9):73-7. PubMed ID: 15577115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical value of two methods to measure parathyroid hormone in chronic renal insufficiency, considering vitamin D metabolism].
    Kovács L; Virágh E; Balogh D; Kálmán B; Lőcsei Z; Toldy E
    Orv Hetil; 2013 Dec; 154(51):2025-36. PubMed ID: 24334134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL; Hristova M; Ho LT; Sprague SM
    Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe vitamin D deficiency in Auckland.
    McGrath N; Singh V; Cundy T
    N Z Med J; 1993 Dec; 106(969):524-6. PubMed ID: 8183494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.
    Ennis JL; Worcester EM; Coe FL; Sprague SM
    J Nephrol; 2016 Feb; 29(1):63-70. PubMed ID: 25736620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D.
    McKenna MJ; Freaney R
    Osteoporos Int; 1998; 8 Suppl 2():S3-6. PubMed ID: 10197175
    [No Abstract]   [Full Text] [Related]  

  • 19. Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correction.
    Brazier M; Kamel S; Maamer M; Agbomson F; Elesper I; Garabedian M; Desmet G; Sebert JL
    J Bone Miner Res; 1995 Nov; 10(11):1753-61. PubMed ID: 8592953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When is Vitamin D contraindicated in dialysis patients?
    Evenepoel P
    Semin Dial; 2009; 22(3):242-4. PubMed ID: 19572999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.